GlassScriptPhysician profile
Thomas A Judge
NPI 1407945462
$1,797.04
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.48 · 2020: $75.51 · 2021: $230 · 2022: $608 · 2023: $541 · 2024: $95.97 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.30 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $627.16 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $306.36 | 2021-2022 | |
| Celgene Corporation | $237.90 | 2022-2023 | Zeposia |
| Medtronic, INC. | $126.22 | 2025 | Endoflip |
| Gilead Sciences, INC. | $117.98 | 2020-2024 | |
| Pfizer INC. | $73.35 | 2021-2023 | |
| Fujifilm Healthcare Americas Corporation | $52.58 | 2025 | |
| Janssen Biotech, INC. | $48.15 | 2023-2024 | Stelara, Simponi Aria, Tremfya |
| Nestle Healthcare Nutrition INC. | $43.06 | 2020-2023 | |
| Aimmune Therapeutics, INC. | $39.14 | 2025 | Zenpep |
| Boston Scientific Corporation | $35.72 | 2023-2024 | Acquire, Dreamtome Rx 49 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.50 | 2019-2021 | |
| Amgen INC. | $15.82 | 2023 | Amjevita, Avsola |
| Steris Corporation | $15.63 | 2021 | |
| Merck Sharp & Dohme LLC | $14.87 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Judge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.